X0306 4/A 2021-10-28 2021-11-01 0001769804 Augmedix, Inc. AUGX 0001827312 McKesson Ventures, LLC ONE POST STREET SAN FRANCISCO CA 94104 1 0 1 0 Common Stock 2021-10-28 4 P 0 112500 4.00 A 4047606 D These securities are held of record by McKesson Ventures LLC ("McKesson"). Jennifer M. Carter, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. As a result, McKesson is a director by deputization for Section 16 purposes. This amendment is being filed to amend the original Form 4 filed on November 1, 2021 (the "Original Form 4") to correct the amount of securities acquired in Column 4 of Table I and amount of securities beneficially owned in Column 5 of Table I which were inadvertently incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged. /s/ David Schulte, Senior Vice President and Managing Director of MCKESSON VENTURES, LLC 2022-09-20